ESC 365 - Routine oral glucose tolerance test to improve risk stratification in acute coronary syndrome patients

ESC2025 Premium Access

Routine oral glucose tolerance test to improve risk stratification in acute coronary syndrome patients

Session: New perspectives in cardiology (2) - Biomarkers and assessing outcomes in coronary artery disease

Topic: Prevention

Speaker: Doctor S. Chiusolo (Pisa, IT)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Simona Chiusolo

Pisa University Hospital, Pisa (Italy)

0 follower

8 more presentations in this session

Discussant - Biomarkers and assessing outcomes in coronary artery disease

Association between cortisol, glucose and hospital mortality in acute coronary syndromes: a causal inference analysis.

Speaker: Doctor S. Swieszkowski (Buenos Aires, AR)

Patients without conventional modifiable risk factors (SMuRFless) presenting with obstructive myocardial infarction face a significantly higher 30-day mortality

Speaker: Doctor S. Fathieh (Buckinghamshire, GB)

Comparative predictive value of troponin I and troponin T for in-hospital ischemic and bleeding events in acute coronary syndrome

Speaker: Doctor J. Costabel (Buenos Aires, AR)

Growth differentiation factor 15 and all-cause and cause-specific mortality in patients with suspected or known coronary artery disease: The ANOX and EXCEED-J Studies

Speaker: Doctor H. Wada (Kyoto, JP)

Access the full session

New perspectives in cardiology (2) - Biomarkers and assessing outcomes in coronary artery disease

Speakers: Doctor S. Chiusolo, Doctor S. Swieszkowski, Doctor S. Fathieh, Doctor J. Costabel, Doctor H. Wada

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources